Des-γ-carboxy Prothrombin (DCP)
Also known as: DCP, Des-gamma-carboxy Prothrombin, PIVKA-II, Protein Induced by Vitamin K Absence
Use
DCP is intended for use as an aid in the risk assessment of patients with chronic liver disease for progression to hepatocellular carcinoma in conjunction with other laboratory findings, imaging studies, and clinical assessment.1
Special Instructions
The test should be used alongside imaging studies for clinical diagnosis. Separate serum from cells and transfer to a plastic transport tube. Submit separate frozen specimens for each test requested to avoid delays.
Limitations
Values obtained with different assay methods or kits cannot be used interchangeably, and results cannot be interpreted as absolute evidence of the presence or absence of malignant disease.
Methodology
Immunoassay (Liquid-phase binding assay (LiBaSys))
Biomarkers
LOINC Codes
- 34444-0
- 34444-0
Result Turnaround Time
5-7 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
0.5 mL
Minimum Volume
0.25 mL
Container
Red-top tube or gel-barrier tube
Collection Instructions
Separate serum from cells and transfer to a plastic transport tube. To avoid delays in turnaround time when requesting multiple tests on frozen samples, please submit separate frozen specimens for each test requested.
Patient Preparation
No special preparations are necessary.
Storage Instructions
Freeze
Causes for Rejection
Gross icterus; gross hemolysis